10.3205/12DGNC475
Müller, N.
N.
Müller
Töpfer, K.
K.
Töpfer
Cartellieri, M.
M.
Cartellieri
Schackert, G.
G.
Schackert
Temme, A.
A.
Temme
Targeting EGFRvIII-positive glioma cells using a novel natural killer cell chimeric antigen receptor type consisting of DAP12 and the single chain antibody variable fragment MR1-1
German Medical Science GMS Publishing House
2012
ConferencePaper
NK-cells
chimeric antigen receptor
EGFRvIII-positive gliomas
610 Medical sciences; Medicine
Deutsche Gesellschaft Für Neurochirurgie|Japanische Gesellschaft Für Neurochirurgie
2012-06-04
2012
en
urn:nbn:de:0183-12dgnc4758
12dgnc475
text/html
63. Jahrestagung der Deutschen Gesellschaft für Neurochirurgie (DGNC), Joint Meeting mit der Japanischen Gesellschaft für Neurochirurgie (JNS)
Objective: Natural killer cells (NK) are able to recognize and kill tumor cells with loss of HLA class I expression and concomitant decrease of HLA-E on their surface. However, most gliomas still express HLA class I, and NK cell reactivity against HLA I-negative solid tumors is blocked by inhibitory[for full text, please go to the a.m. URL]
63. Jahrestagung der Deutschen Gesellschaft für Neurochirurgie (DGNC), Joint Meeting mit der Japanischen Gesellschaft für Neurochirurgie (JNS)